Comparative in vitro evaluation of dequalinium B, a new boron carrier for neutron capture therapy (NCT)

Anticancer Research

Volumn 20, Issue 5 B, 2000, Pages 3395-3402

  Adams, D M ^a   Ji, W ^a   Barth, R F ^a   Tjarks, W ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Boron neutron capture therapy; Boronated dequalinium; Dequalinium; MKT 077; RH 123; Tetraphenylphosphonium chloride

Indexed keywords

1 ETHYL 2 [[3 ETHYL 5 (3 METHYLBENZOTHIAZOLIN 2 YLIDENE) 4 OXOTHIAZOLIDIN 2 YLIDENE]METHYL]PYRIDINIUM CHLORIDE; BORON DERIVATIVE; DEQUALINIUM; DEQUALINIUM B; TETRAPHENYLPHOSPHONIUM; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; HUMAN; HUMAN CELL; LIPOPHILICITY; NEUTRON CAPTURE THERAPY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TARGET CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; BORANES; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; CELL LINE; CERCOPITHECUS AETHIOPS; DEQUALINIUM; DRUG CARRIERS; EPITHELIAL CELLS; GLIOMA; HUMANS; KB CELLS; ONIUM COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; PYRIDINES; RATS; RATS, INBRED F344; RHODAMINE 123; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0033639165     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. The chemistry of neutron capture therapy
2. The role of chemistry in the development of boron neutron capture therapy of cancer
3. Boron neutron capture therapy of brain tumors: Enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine
4. The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCVII tumors in mice
5. Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapy
6. The use of boron clusters in the rational design of boronated nucleosides for neutron capture therapy of cancer
7. Nucleic acids and nucleosides containing carboranes
8. Chemistry and biology of some low molecular weight boron compounds for BNCT
9. Mitochondria are the functional intracelluar target for a photosensitizing boronated porphyrin
10. Boronated protoporphyrin (BOPP): Localization in lysosomes of the human glioma cell line SF-767 with uptake modulated by lipoprotein levels
11. Selective retention of rhodamine-123 by malignant glioma in the rat
12. MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation
13. Dequalinium, a topical antimicroila agent, displays anticarcinoma activity based on selective mitochondrial accumulation
14. 3H-tetraphenylphosphonium by nervous system tumor cells
15. Mitochondrial membrane potential in living cells
16. Recent advances in the study of mitochondria in living cells
17. Photodynamic effects of hematoporphyrin derivative on the uptake of rhodamine 123 by mitochondria of intact murine L929 fibroblasts and chinese hamster ovary K1 cells
18. Relationship of mitochondrial and cellular adenosine triphosphate levels to hematoporphyrin derivative-induced photosensitization in R3230AC mammary tumors
19. Mitochondrial toxicity of cationic photosensitizer for photochemotherapy
20. Photoactivation enhances the mitochondrial toxicity of the cationic rhodacyanine MKT-077
21. Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells
22. Relationship between photodynamically induced damage to various cellular parameters and loss of clonogenicity in different cell types with hematoporphyrin derivatives as sensitizer
23. The effects of a chalcogenapyrylium dye with and without photolysis on mitochondrial function in normal and tumor cells
24. Synthesis of a boronated phenanthridinium derivative for potential use in boron neutron capture therapy
25. Synthesis and evaluation of novel rhodacyanine dyes that exhibit antitumor activity
26. Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy
27. Increased rhodamine 123 uptake by carcinoma cells
28. + channel blockers. Investigations on the role of the of the charged heterocycle
29. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor-cell lines
30. Unusually strong lipohilicity of fat or super amino-acids, including a new reference value for glycine
31. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy
32. MKT-077
33. Rhodamine 123 is selectively toxic and preferentially retained in carcinoma cells in vitro
34. Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077
35. In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function
36. Inhibition of bovine heart mitochondrial and paracoccus denitrificans NADH-ubiquinone reductase by dequalinium chloride and three structurally related quinolinium compounds
37. Rhodamine 123 inhibits bioenergetic function in isolated rat liver mitochondria
38. Inhibition and photoinactivation of the bovine heart mitochondrial F1-ATPase by the cytotoxic agent, dequalinium
39. Selective antimitochondrial agents inhibit calmodulin
40. Inhibition of rodent protein kinase C by the anticarcinoma agent dequalinium